Bansal Roofing Products Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 12:07 am

Quick Insight

Bansal Roofing Products Ltd, operating in the plastics sheets/films industry, shows promising financial indicators with a P/E ratio of 24.8 and ROE and ROCE at 18.2% and 22.4% respectively. The company's OPM stands at 8.40% with a healthy Net Profit of 5.54 Cr. Notably, with a MarketCap of 166 Cr. and Reserves of 20 Cr., Bansal Roofing Products Ltd has a strong financial foundation. Furthermore, the company's conservative borrowing of ₹5Cr and a comfortable Interest Coverage Ratio of 23.48x indicate a sound liquidity position. Investors may find Bansal Roofing Products Ltd an attractive investment option given its robust financial performance and prudent financial management.

Competitors of Bansal Roofing Products Ltd

All Competitor Stocks of Bansal Roofing Products Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:40 pm

Below is a detailed analysis of the quarterly data for Bansal Roofing Products Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 36.20 Cr.. The value appears strong and on an upward trend. It has increased from 29.46 Cr. (Mar 2025) to 36.20 Cr., marking an increase of 6.74 Cr..
• For Expenses, as of Jun 2025, the value is 33.16 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.52 Cr. (Mar 2025) to 33.16 Cr., marking an increase of 6.64 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.04 Cr.. The value appears strong and on an upward trend. It has increased from 2.94 Cr. (Mar 2025) to 3.04 Cr., marking an increase of 0.10 Cr..
• For OPM %, as of Jun 2025, the value is 8.40%. The value appears to be declining and may need further review. It has decreased from 9.98% (Mar 2025) to 8.40%, marking a decrease of 1.58%.
• For Other Income, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
• For Interest, as of Jun 2025, the value is 0.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Mar 2025) to 0.08 Cr., marking an increase of 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 0.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.37 Cr. (Mar 2025) to 0.40 Cr., marking an increase of 0.03 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.57 Cr.. The value appears strong and on an upward trend. It has increased from 2.51 Cr. (Mar 2025) to 2.57 Cr., marking an increase of 0.06 Cr..
• For Tax %, as of Jun 2025, the value is 21.40%. The value appears to be improving (decreasing) as expected. It has decreased from 25.90% (Mar 2025) to 21.40%, marking a decrease of 4.50%.
• For Net Profit, as of Jun 2025, the value is 2.02 Cr.. The value appears strong and on an upward trend. It has increased from 1.86 Cr. (Mar 2025) to 2.02 Cr., marking an increase of 0.16 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.53. The value appears strong and on an upward trend. It has increased from 1.41 (Mar 2025) to 1.53, marking an increase of 0.12.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 4:16 am

Growth

Last Updated: September 5, 2025, 2:36 pm

Balance Sheet

Last Updated: August 11, 2025, 3:26 pm

Below is a detailed analysis of the balance sheet data for Bansal Roofing Products Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 13.00 Cr..
• For Reserves, as of Mar 2025, the value is 20.00 Cr.. The value appears strong and on an upward trend. It has increased from 14.00 Cr. (Mar 2024) to 20.00 Cr., marking an increase of 6.00 Cr..
• For Borrowings, as of Mar 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 4.00 Cr. (Mar 2024) to 5.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2024) to 16.00 Cr., marking an increase of 8.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 54.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 40.00 Cr. (Mar 2024) to 54.00 Cr., marking an increase of 14.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 30.00 Cr.. The value appears strong and on an upward trend. It has increased from 25.00 Cr. (Mar 2024) to 30.00 Cr., marking an increase of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 3.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to 23.00 Cr., marking an increase of 13.00 Cr..
• For Total Assets, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 40.00 Cr. (Mar 2024) to 54.00 Cr., marking an increase of 14.00 Cr..

Notably, the Reserves (20.00 Cr.) exceed the Borrowings (5.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

No data available for the No. of Shareholders chart.

Key Financial Ratios

After reviewing the key financial ratios for Bansal Roofing Products Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.20. This value is below the healthy minimum of 5. It has increased from 2.69 (Mar 24) to 4.20, marking an increase of 1.51.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.20. This value is below the healthy minimum of 5. It has increased from 2.69 (Mar 24) to 4.20, marking an increase of 1.51.
• For Cash EPS (Rs.), as of Mar 25, the value is 5.32. This value is within the healthy range. It has increased from 3.66 (Mar 24) to 5.32, marking an increase of 1.66.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 25.14. It has increased from 20.94 (Mar 24) to 25.14, marking an increase of 4.20.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 25.14. It has increased from 20.94 (Mar 24) to 25.14, marking an increase of 4.20.
• For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 1.00, marking an increase of 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 73.29. It has decreased from 80.09 (Mar 24) to 73.29, marking a decrease of 6.80.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 7.06. This value is within the healthy range. It has increased from 5.05 (Mar 24) to 7.06, marking an increase of 2.01.
• For PBIT / Share (Rs.), as of Mar 25, the value is 5.94. This value is within the healthy range. It has increased from 4.08 (Mar 24) to 5.94, marking an increase of 1.86.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.64. This value is within the healthy range. It has increased from 3.64 (Mar 24) to 5.64, marking an increase of 2.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.20. This value is within the healthy range. It has increased from 2.69 (Mar 24) to 4.20, marking an increase of 1.51.
• For PBDIT Margin (%), as of Mar 25, the value is 9.62. This value is below the healthy minimum of 10. It has increased from 6.30 (Mar 24) to 9.62, marking an increase of 3.32.
• For PBIT Margin (%), as of Mar 25, the value is 8.10. This value is below the healthy minimum of 10. It has increased from 5.09 (Mar 24) to 8.10, marking an increase of 3.01.
• For PBT Margin (%), as of Mar 25, the value is 7.69. This value is below the healthy minimum of 10. It has increased from 4.54 (Mar 24) to 7.69, marking an increase of 3.15.
• For Net Profit Margin (%), as of Mar 25, the value is 5.73. This value is within the healthy range. It has increased from 3.35 (Mar 24) to 5.73, marking an increase of 2.38.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.71. This value is within the healthy range. It has increased from 12.84 (Mar 24) to 16.71, marking an increase of 3.87.
• For Return on Capital Employeed (%), as of Mar 25, the value is 22.02. This value is within the healthy range. It has increased from 17.25 (Mar 24) to 22.02, marking an increase of 4.77.
• For Return On Assets (%), as of Mar 25, the value is 10.28. This value is within the healthy range. It has increased from 8.90 (Mar 24) to 10.28, marking an increase of 1.38.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 24) to 0.03, marking a decrease of 0.06.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.14. This value is within the healthy range. It has decreased from 0.15 (Mar 24) to 0.14, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.06. It has decreased from 2.75 (Mar 24) to 2.06, marking a decrease of 0.69.
• For Current Ratio (X), as of Mar 25, the value is 1.24. This value is below the healthy minimum of 1.5. It has increased from 1.16 (Mar 24) to 1.24, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.31, marking a decrease of 0.16.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.06. This value is within the healthy range. It has decreased from 11.63 (Mar 24) to 6.06, marking a decrease of 5.57.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 23.48. This value is within the healthy range. It has increased from 11.43 (Mar 24) to 23.48, marking an increase of 12.05.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.98. This value is within the healthy range. It has increased from 7.08 (Mar 24) to 14.98, marking an increase of 7.90.
• For Enterprise Value (Cr.), as of Mar 25, the value is 134.84. It has increased from 108.74 (Mar 24) to 134.84, marking an increase of 26.10.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has increased from 1.03 (Mar 24) to 1.40, marking an increase of 0.37.
• For EV / EBITDA (X), as of Mar 25, the value is 14.49. This value is within the healthy range. It has decreased from 16.33 (Mar 24) to 14.49, marking a decrease of 1.84.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.35, marking an increase of 0.36.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 3.93. This value exceeds the healthy maximum of 3. It has increased from 3.80 (Mar 24) to 3.93, marking an increase of 0.13.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has increased from 0.99 (Mar 24) to 1.35, marking an increase of 0.36.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness